首页> 美国卫生研究院文献>Journal of Innate Immunity >Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance
【2h】

Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance

机译:反映慢性阻塞性肺疾病和相关呼吸系统疾病的动物模型:将临床前数据转化为临床相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease (COPD) affects the lives of an ever-growing number of people worldwide. The lack of understanding surrounding the pathophysiology of the disease and its progression has led to COPD becoming the third leading cause of death worldwide. COPD is incurable, with current treatments only addressing associated symptoms and sometimes slowing its progression, thus highlighting the need to develop novel treatments. However, this has been limited by the lack of experimental standardization within the respiratory disease research area. A lack of coherent animal models that accurately represent all aspects of COPD clinical presentation makes the translation of promising in vitro data to human clinical trials exceptionally challenging. Here, we review current knowledge within the COPD research field, with a focus on current COPD animal models. Moreover, we include a set of advantages and disadvantages for the selection of pre-clinical models for the identification of novel COPD treatments.
机译:慢性阻塞性肺疾病(COPD)影响着全世界不断增长的人们的生活。对疾病的病理生理学及其进展缺乏了解导致COPD成为全球第三大死亡原因。慢性阻塞性肺病是无法治愈的,目前的治疗方法仅能解决相关症状,有时会减缓其进展,因此突出了开发新疗法的必要性。但是,这已经由于呼吸系统疾病研究领域缺乏实验标准化而受到限制。缺乏能准确代表COPD临床表现各个方面的连贯动物模型,使得将有希望的体外数据转化为人类临床试验的挑战异常艰巨。在这里,我们回顾了COPD研究领域中的最新知识,重点是当前的COPD动物模型。此外,我们在选择临床前模型以鉴定新型COPD治疗方法时包括了一系列利弊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号